KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 142 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $24,479,000 | -1.6% | 7,199,683 | +8.9% | 0.00% | 0.0% |
| Q2 2018 | $24,866,000 | +0.0% | 6,613,445 | +8.8% | 0.00% | 0.0% |
| Q1 2018 | $24,863,000 | -12.3% | 6,078,614 | -0.3% | 0.00% | 0.0% |
| Q4 2017 | $28,356,000 | -33.3% | 6,097,948 | +1.9% | 0.00% | -50.0% |
| Q3 2017 | $42,498,000 | +8.7% | 5,985,567 | +10.7% | 0.00% | 0.0% |
| Q2 2017 | $39,085,000 | +17.2% | 5,405,826 | -0.2% | 0.00% | 0.0% |
| Q1 2017 | $33,359,000 | +83297.5% | 5,415,331 | +80281.9% | 0.00% | – |
| Q4 2016 | $40,000 | -4.8% | 6,737 | -15.6% | 0.00% | – |
| Q3 2016 | $42,000 | -20.8% | 7,983 | 0.0% | 0.00% | – |
| Q2 2016 | $53,000 | +89.3% | 7,983 | +30.4% | 0.00% | – |
| Q1 2016 | $28,000 | +133.3% | 6,123 | +157.6% | 0.00% | – |
| Q4 2015 | $12,000 | +50.0% | 2,377 | 0.0% | 0.00% | – |
| Q3 2015 | $8,000 | -66.7% | 2,377 | 0.0% | 0.00% | – |
| Q2 2015 | $24,000 | -20.0% | 2,377 | 0.0% | 0.00% | – |
| Q1 2015 | $30,000 | -11.8% | 2,377 | 0.0% | 0.00% | – |
| Q4 2014 | $34,000 | +3.0% | 2,377 | 0.0% | 0.00% | – |
| Q3 2014 | $33,000 | -8.3% | 2,377 | 0.0% | 0.00% | – |
| Q2 2014 | $36,000 | -29.4% | 2,377 | -21.6% | 0.00% | – |
| Q1 2014 | $51,000 | +88.9% | 3,032 | +43.7% | 0.00% | – |
| Q4 2013 | $27,000 | +28.6% | 2,110 | 0.0% | 0.00% | – |
| Q3 2013 | $21,000 | +31.2% | 2,110 | 0.0% | 0.00% | – |
| Q2 2013 | $16,000 | – | 2,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |